Clinical Trials in Texas

Showing 5021-5040 of 15,101 trials

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Determine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of VIP152 (BAY 1251152) as monotherapy or in combination in patients with solid tumors and aggressive non-hodgkin's lymphoma (NHL).

Neoplasms

Vincerx Pharma, Inc.110 participantsStarted Feb 2016

Springdale, Arkansas, United States • Louisville, Kentucky, United States • Silver Spring, Maryland, United States +13 more locations

COMPLETEDPhase 1/255 miles

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

NCT05364021

The objective of this study is to assess the safety, tolerability, efficacy, and pharmacokinetics of adjunctive therapy of LP352 in adults and adolescents with developmental and epileptic encephalopathies.

Developmental and Epileptic EncephalopathyDravet SyndromeLennox Gastaut Syndrome

Longboard Pharmaceuticals52 participantsStarted Mar 2022

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Downey, California, United States +31 more locations

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

Find Trials by Condition in Texas

A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening

A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

Behavioral Health Interdisciplinary Program - Collaborative Chronic Care Model (BHIP-CCM) Enhancement Project 2.0

Wound Assessment Using Spectral Imaging US

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer

Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions